Results 271 to 280 of about 118,295 (302)
Some of the next articles are maybe not open access.

[Interferon-gamma release assay on suspicion of active tuberculosis?].

Ugeskrift for laeger, 2009
The purpose of this retrospective study was to outline the practical use and clinical value of the immunodiagnostic interferon-gamma release assay (IGRA) on suspicion of active Mycobacterium tuberculosis (TB) infection.A retrospective study of all patients (n=91) tested with IGRA (Quantiferon-TB-Gold, Celletis International, Australia) for M ...
Andrea, Browatzki   +1 more
openaire   +1 more source

The CRISPR–Cas toolbox for analytical and diagnostic assay development

Chemical Society Reviews, 2021
Wei Feng, Qianfan Yang, Feng Li
exaly  

PD-L1 as a biomarker of response to immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
Mary Beth Beasley   +2 more
exaly  

Interferon-gamma Release Assays - Erwiderung

DMW - Deutsche Medizinische Wochenschrift, 2007
M Löbermann, E. C Reisinger, W Frank
openaire   +1 more source

Interferon Gamma Release Assays (IGRAs)

2012
G. Citerio   +42 more
openaire   +1 more source

A serological assay to detect SARS-CoV-2 seroconversion in humans

Nature Medicine, 2020
Fatima Amanat   +2 more
exaly  

Nanozyme-catalysed CRISPR assay for preamplification-free detection of non-coding RNAs

Nature Nanotechnology, 2022
Marta Broto   +2 more
exaly  

Development of a clinical polygenic risk score assay and reporting workflow

Nature Medicine, 2022
Peter Kraft, ScD   +2 more
exaly  

Home - About - Disclaimer - Privacy